Tetrasodium EDTA Is Effective at Eradicating Biofilms Formed by Clinically Relevant Microorganisms from Patients' Central Venous Catheters

Fangning Liu, Satyender Hansra, Gordon Crockford, Wolfgang Köster, Brenda J Allan, Joseph M Blondeau, Chantal Lainesse, Aaron P White, Fangning Liu, Satyender Hansra, Gordon Crockford, Wolfgang Köster, Brenda J Allan, Joseph M Blondeau, Chantal Lainesse, Aaron P White

Abstract

Central venous access devices (CVADs) are an essential component of modern health care. However, their prolonged use commonly results in microbial colonization, which carries the potential risk of hospital-acquired bloodstream infections. These infections complicate the treatment of already sick individuals and cost the existing health care systems around the world millions of dollars. The microbes that colonize CVADs typically form multicellular biofilms that are difficult to dislodge and are resistant to antimicrobial treatments. Clinicians are searching for better ways to extend the working life span of implanted CVADs, by preventing colonization and reducing the risk of bloodstream infections. In this study, we analyzed 210 bacterial and fungal isolates from colonized CVADs or human bloodstream infections from two hospitals geographically separated in the east and west of Canada and screened the isolates for biofilm formation in vitro Twenty isolates, representing 12 common, biofilm-forming species, were exposed to 4% tetrasodium EDTA, an antimicrobial lock solution that was recently approved in Canada for use as a medical device. The EDTA solution was effective at eradicating surface-attached biofilms from each microbial species, indicating that it could likely be used to prevent biofilm growth within CVADs and to eliminate established biofilms. This new lock solution fits with antibiotic stewardship programs worldwide by sparing the use of important antibiotic agents, targeting prevention rather than the expensive treatment of hospital-acquired infections.IMPORTANCE The colonization of catheters by microorganisms often precludes their long-term use, which can be a problem for human patients that have few body sites available for new catheters. The colonizing organisms often form biofilms, and increasingly these organisms are resistant to multiple antibiotics, making them difficult to treat. In this article, we have taken microorganisms that are associated with biofilm formation in catheters from two Canadian hospitals and tested them with tetrasodium EDTA, a new antimicrobial catheter lock solution. Tetrasodium EDTA was effective at eliminating Gram-positive, Gram-negative, and fungal species and represents a promising alternative to antibiotic treatment with less chance of the organisms developing resistance. We expect that our results will be of interest to researchers and clinicians and will lead to improved patient care.

Keywords: EDTA; Gram-negative; Gram-positive; antibiotic resistance; antimicrobial; biofilms; catheters; central venous access devices; fungi; minimum inhibitory concentration.

Copyright © 2018 Liu et al.

Figures

FIG 1
FIG 1
Biofilm screening of S. epidermidis isolates. Twenty-five S. epidermidis isolates originating from central venous access devices were inoculated into 96-well plates and grown for 24 h at 37°C in biofilm media: M9, M9 minimal media; CAA, Casamino Acids; TSB, tryptic soy broth. Biofilm cell mass in each well was quantitated by crystal violent staining and measuring the absorbance of the resulting solution at 590 nm (A590). Bars represent the average values and error bars the standard deviations from 6 biological replicates. The dashed horizontal line represents the average A590 value from uninoculated control wells. Stars denote isolates that were judged to have robust biofilm formation. Isolate 170 (arrow) was chosen for subsequent testing.
FIG 2
FIG 2
Determination of MIC, MBC, and MBEC values of tetrasodium EDTA against Staphylococcus isolates cultured from central venous access devices. Individual isolates of S. epidermidis (A, B, and C) and methicillin-resistant S. aureus (D, E, and F) were tested in MIC (A and D), MBC (B and E), and MBEC (C and F) assays. Horizontal bars represent the mean OD600 or viable bacterial cell (CFU/ml) values after cultures were exposed to increasing amounts of tetrasodium EDTA. Arrows represent MIC, MBC, and MBEC values. The dashed horizontal lines on each graph represent the background OD600 values in uninoculated control wells (A and D) or the CFU limit of detection (B, C, E, and F). Three biological replicate cultures were tested in duplicate or triplicate for each type of assay; each dot represents one replicate.
FIG 3
FIG 3
Minimum exposure time to kill bacterial/fungal biofilms with 4% tetrasodium EDTA. In vitro biofilms formed by Gram-positive bacteria (A), Gram-negative bacteria (B), fungal species (C), and control bacteria (D) were formed on polystyrene pegs prior to testing. For each graph, the hatched bar (0 h) shows the starting CFU/ml values measured from control pegs (n = 8). Formed biofilms were exposed to 4% tetrasodium EDTA (black bars) or water (gray bars) for the times shown; four biological replicates with four technical replicates (n = 16) were analyzed for treatment groups, along with four biological replicates with two technical replicates (n = 8) for water controls. Bars represent the average CFU/ml detected, and error bars represent the standard deviation. The time points where biofilms were killed near or at the limit of detection (dotted line [125 CFU/ml]) are highlighted in yellow. Values from each treatment group were compared to the corresponding water controls by unpaired t tests with Welch’s correction. Statistical significance is noted above each treatment bar: ns, not significant (P > 0.05); *, P < 0.05. Arrows denote the minimum exposure times required for complete eradication of the bacterial/fungal biofilms.
FIG 3
FIG 3
Minimum exposure time to kill bacterial/fungal biofilms with 4% tetrasodium EDTA. In vitro biofilms formed by Gram-positive bacteria (A), Gram-negative bacteria (B), fungal species (C), and control bacteria (D) were formed on polystyrene pegs prior to testing. For each graph, the hatched bar (0 h) shows the starting CFU/ml values measured from control pegs (n = 8). Formed biofilms were exposed to 4% tetrasodium EDTA (black bars) or water (gray bars) for the times shown; four biological replicates with four technical replicates (n = 16) were analyzed for treatment groups, along with four biological replicates with two technical replicates (n = 8) for water controls. Bars represent the average CFU/ml detected, and error bars represent the standard deviation. The time points where biofilms were killed near or at the limit of detection (dotted line [125 CFU/ml]) are highlighted in yellow. Values from each treatment group were compared to the corresponding water controls by unpaired t tests with Welch’s correction. Statistical significance is noted above each treatment bar: ns, not significant (P > 0.05); *, P < 0.05. Arrows denote the minimum exposure times required for complete eradication of the bacterial/fungal biofilms.
FIG 3
FIG 3
Minimum exposure time to kill bacterial/fungal biofilms with 4% tetrasodium EDTA. In vitro biofilms formed by Gram-positive bacteria (A), Gram-negative bacteria (B), fungal species (C), and control bacteria (D) were formed on polystyrene pegs prior to testing. For each graph, the hatched bar (0 h) shows the starting CFU/ml values measured from control pegs (n = 8). Formed biofilms were exposed to 4% tetrasodium EDTA (black bars) or water (gray bars) for the times shown; four biological replicates with four technical replicates (n = 16) were analyzed for treatment groups, along with four biological replicates with two technical replicates (n = 8) for water controls. Bars represent the average CFU/ml detected, and error bars represent the standard deviation. The time points where biofilms were killed near or at the limit of detection (dotted line [125 CFU/ml]) are highlighted in yellow. Values from each treatment group were compared to the corresponding water controls by unpaired t tests with Welch’s correction. Statistical significance is noted above each treatment bar: ns, not significant (P > 0.05); *, P < 0.05. Arrows denote the minimum exposure times required for complete eradication of the bacterial/fungal biofilms.

References

    1. World Health Organization 2011. Report on the burden of endemic health care-associated infection worldwide. World Health Organization, Geneva, Switzerland: .
    1. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, Lipsett PA, Masur H, Mermel LA, Pearson ML, Raad II, Randolph AG, Rupp ME, Saint S, Healthcare Infection Control Practices Advisory Committee (HICPAC). 2011. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 52:e162–e193. doi:10.1093/cid/cir257.
    1. Murphy D, Whiting J. 2007. Dispelling the myths: the true cost of healthcare-associated infections. Association for Professionals in Infection Control and Epidemiology (APIC), Washington, DC.
    1. Little MA, O'Riordan A, Lucey B, Farrell M, Lee M, Conlon PJ, Walshe JJ. 2001. A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 16:2194–2200. doi:10.1093/ndt/16.11.2194.
    1. Chopra V, O'Horo JC, Rogers MAM, Maki DG, Safdar N. 2013. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 34:908–918. doi:10.1086/671737.
    1. Ryder MA. 2005. Catheter-related infections: it's all about biofilm. Top Adv Pract Nursing 5 .
    1. Gominet M, Compain F, Beloin C, Lebeaux D. 2017. Central venous catheters and biofilms: where do we stand in 2017? APMIS 125:365–375. doi:10.1111/apm.12665.
    1. Schiffer CA, Mangu PB, Wade JC, Camp-Sorrell D, Cope DG, El-Rayes BF, Gorman M, Ligibel J, Mansfield P, Levine M. 2013. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31:1357–1370. doi:10.1200/JCO.2012.45.5733.
    1. Zhang L, Sriprakash KS, McMillan D, Gowardman JR, Patel B, Rickard CM. 2010. Microbiological pattern of arterial catheters in the intensive care unit. BMC Microbiol 10:266. doi:10.1186/1471-2180-10-266.
    1. Lai C-H, Wong W-W, Chin C, Huang C-K, Lin H-H, Chen W-F, Yu K-W, Liu C-Y. 2006. Central venous catheter-related Stenotrophomonas maltophilia bacteraemia and associated relapsing bacteraemia in haematology and oncology patients. Clin Microbiol Infect 12:986–991. doi:10.1111/j.1469-0691.2006.01511.x.
    1. Goossens GA. 2015. Flushing and locking of venous catheters: available evidence and evidence deficit. Nurs Res Pract 2015:985686. doi:10.1155/2015/985686.
    1. Bleyer AJ, Murea M. 2011. Antimicrobial catheter locks: searching for the ideal solution. J Am Soc Nephrol 22:1781–1782. doi:10.1681/ASN.2011080839.
    1. Donlan RM. 2011. Biofilm elimination on intravascular catheters: important considerations for the infectious disease practitioner. Clin Infect Dis 52:1038–1045. doi:10.1093/cid/cir077.
    1. Kostaki M, Chorianopoulos N, Braxou E, Nychas G-J, Giaouris E. 2012. Differential biofilm formation and chemical disinfection resistance of sessile cells of Listeria monocytogenes strains under monospecies and dual-species (with Salmonella enterica) conditions. Appl Environ Microbiol 78:2586–2595. doi:10.1128/AEM.07099-11.
    1. Fey PD, Olson ME. 2010. Current concepts in biofilm formation of Staphylococcus epidermidis. Future Microbiol 5:917–933. doi:10.2217/fmb.10.56.
    1. Flemming H-C, Wingender J, Szewzyk U, Steinberg P, Rice SA, Kjelleberg S. 2016. Biofilms: an emergent form of bacterial life. Nat Rev Microbiol 14:563–575. doi:10.1038/nrmicro.2016.94.
    1. Mermel LA. 2014. What is the evidence for intraluminal colonization of hemodialysis catheters? Kidney Int 86:28–33. doi:10.1038/ki.2013.527.
    1. Kong EF, Tsui C, Kucharíková S, Andes D, Van Dijck P, Jabra-Rizk MA. 2016. Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans biofilm matrix. mBio 7:e01365-16. doi:10.1128/mBio.01365-16.
    1. Lebeaux D, Ghigo J-M, Beloin C. 2014. Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev 78:510–543. doi:10.1128/MMBR.00013-14.
    1. Hadaway L. 2006. Heparin locking for central venous catheters. J Assoc Vasc Access 11:224–231. doi:10.2309/java.11-4-17.
    1. Shanks RMQ, Donegan NP, Graber ML, Buckingham SE, Zegans ME, Cheung AL, O'Toole GA. 2005. Heparin stimulates Staphylococcus aureus biofilm formation. Infect Immun 73:4596–4606. doi:10.1128/IAI.73.8.4596-4606.2005.
    1. Proescher F. 1951. Anti-coagulant properties of ethylene bis-iminodiacetic acid. Proc Soc Exp Biol Med 76:619–620. doi:10.3181/00379727-76-18577.
    1. Lam NYL, Rainer TH, Chiu RWK, Lo YMD. 2004. EDTA is a better anticoagulant than heparin or citrate for delayed blood processing for plasma DNA analysis. Clin Chem 50:256–257. doi:10.1373/clinchem.2003.026013.
    1. Chandra J, Long L, Isham N, Mukherjee PK, DiSciullo G, Appelt K, Ghannoum MA. 2018. In vitro and in vivo activity of a novel catheter lock solution against bacterial and fungal biofilms. Antimicrob Agents Chemother 62:e00722-18. doi:10.1128/AAC.00722-18.
    1. Hogan S, Zapotoczna M, Stevens NT, Humphreys H, O'Gara JP, O'Neill E. 2016. In vitro approach for identification of the most effective agents for antimicrobial lock therapy in the treatment of intravascular catheter-related infections caused by Staphylococcus aureus. Antimicrob Agents Chemother 60:2923–2931. doi:10.1128/AAC.02885-15.
    1. Kite P, Eastwood K, Sugden S, Percival SL. 2004. Use of in vivo-generated biofilms from hemodialysis catheters to test the efficacy of a novel antimicrobial catheter lock for biofilm eradication in vitro. J Clin Microbiol 42:3073–3076. doi:10.1128/JCM.42.7.3073-3076.2004.
    1. Percival SL, Kite P, Eastwood K, Murga R, Carr J, Arduino MJ, Donlan RM. 2005. Tetrasodium EDTA as a novel central venous catheter lock solution against biofilm. Infect Control Hosp Epidemiol 26:515–519. doi:10.1086/502577.
    1. Kanaa M, Wright MJ, Akbani H, Laboi P, Bhandari S, Sandoe JAT. 2015. Cathasept line lock and microbial colonization of tunneled hemodialysis catheters: a multicenter randomized controlled trial. Am J Kidney Dis 66:1015–1023. doi:10.1053/j.ajkd.2015.04.047.
    1. Yousif A, Jamal MA, Raad I. 2015. Biofilm-based central line-associated bloodstream infections. Adv Exp Med Biol 830:157–179. doi:10.1007/978-3-319-11038-7_10.
    1. Kaur M, Gupta V, Gombar S, Chander J, Sahoo T. 2015. Incidence, risk factors, microbiology of venous catheter associated bloodstream infections—a prospective study from a tertiary care hospital. Indian J Med Microbiol 33:248–254. doi:10.4103/0255-0857.153572.
    1. Strasheim W, Kock MM, Ueckermann V, Hoosien E, Dreyer AW, Ehlers MM. 2015. Surveillance of catheter-related infections: the supplementary role of the microbiology laboratory. BMC Infect Dis 15:5. doi:10.1186/s12879-014-0743-5.
    1. Rijnders BJA, Van Wijngaerden E, Peetermans WE. 2002. Catheter-tip colonization as a surrogate end point in clinical studies on catheter-related bloodstream infection: how strong is the evidence? Clin Infect Dis 35:1053–1058. doi:10.1086/342905.
    1. Sherertz RJ, Heard SO, Raad II. 1997. Diagnosis of triple-lumen catheter infection: comparison of roll plate, sonication, and flushing methodologies. J Clin Microbiol 35:641–646.
    1. Guembe M, Martín-Rabadán P, Cruces R, Pérez Granda MJ, Bouza E. 2016. Sonicating multi-lumen sliced catheter tips after the roll-plate technique improves the detection of catheter colonization in adults. J Microbiol Methods 122:20–22. doi:10.1016/j.mimet.2016.01.004.
    1. Guembe M, Marín M, Martín-Rabadán P, Echenagusia A, Camúñez F, Rodríguez-Rosales G, Simó G, Echenagusia M, Bouza E, GEIDI Study Group. 2013. Use of universal 16S rRNA gene PCR as a diagnostic tool for venous access port-related bloodstream infections. J Clin Microbiol 51:799–804. doi:10.1128/JCM.02414-12.
    1. Public Health Agency of Canada. 2014. Central venous catheter-associated blood stream infections in intensive care units in Canadian acute-care hospitals: surveillance report January 1, 2006 to December 31, 2006 and January 1, 2009 to December 31, 2011. Public Health Agency of Canada, Ottawa, Ontario, Canada.
    1. Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. 2000. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods 40:175–179. doi:10.1016/S0167-7012(00)00122-6.
    1. Pankey GA, Sabath LD. 2004. Clinical relevance of bacteriostatic versus bactericidal mechanisms of action in the treatment of Gram-positive bacterial infections. Clin Infect Dis 38:864–870. doi:10.1086/381972.
    1. Harrison JJ, Stremick CA, Turner RJ, Allan ND, Olson ME, Ceri H. 2010. Microtiter susceptibility testing of microbes growing on peg lids: a miniaturized biofilm model for high-throughput screening. Nat Protoc 5:1236–1254. doi:10.1038/nprot.2010.71.
    1. Holmes AH, Moore LSP, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJV. 2016. Understanding the mechanisms and drivers of antimicrobial resistance. Lancet 387:176–187. doi:10.1016/S0140-6736(15)00473-0.
    1. Review on Antimicrobial Resistance 2016. Tackling drug-resistant infections globally: final report and recommendations. O'Neill J. (ed), Review on Antimicrobial Resistance, London, United Kingdom: .
    1. Costerton JW, Stewart PS, Greenberg EP. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318–1322. doi:10.1126/science.284.5418.1318.
    1. Uppuluri P, Lopez-Ribot JL. 2016. Go forth and colonize: dispersal from clinically important microbial biofilms. PLoS Pathog 12:e1005397. doi:10.1371/journal.ppat.1005397.
    1. Harriott MM, Noverr MC. 2009. Candida albicans and Staphylococcus aureus form polymicrobial biofilms: effects on antimicrobial resistance. Antimicrob Agents Chemother 53:3914–3922. doi:10.1128/AAC.00657-09.
    1. Stressmann FA, Couve-Deacon E, Chainier D, Chauhan A, Wessel A, Durand-Fontanier S, Escande M-C, Kriegel I, Francois B, Ploy M-C, Beloin C, Ghigo J-M. 2017. Comparative analysis of bacterial community composition and structure in clinically symptomatic and asymptomatic central venous catheters. mSphere 2:e00146-17. doi:10.1128/mSphere.00146-17.
    1. Kanaa M, Wright MJ, Sandoe JAT. 2010. Examination of tunnelled haemodialysis catheters using scanning electron microscopy. Clin Microbiol Infect 16:780–786. doi:10.1111/j.1469-0691.2009.02952.x.
    1. Zhang L, Gowardman J, Morrison M, Krause L, Playford EG, Rickard CM. 2014. Molecular investigation of bacterial communities on intravascular catheters: no longer just Staphylococcus. Eur J Clin Microbiol Infect Dis 33:1189–1198. doi:10.1007/s10096-014-2058-2.
    1. Cherifi S, Byl B, Deplano A, Nonhoff C, Denis O, Hallin M. 2013. Comparative epidemiology of Staphylococcus epidermidis isolates from patients with catheter-related bacteremia and from healthy volunteers. J Clin Microbiol 51:1541–1547. doi:10.1128/JCM.03378-12.
    1. Widerström M, Wiström J, Sjöstedt A, Monsen T. 2012. Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis 31:7–20. doi:10.1007/s10096-011-1270-6.
    1. Wolcott R, Costerton JW, Raoult D, Cutler SJ. 2013. The polymicrobial nature of biofilm infection. Clin Microbiol Infect 19:107–112. doi:10.1111/j.1469-0691.2012.04001.x.
    1. Cowan MM, Warren TM, Fletcher M. 1991. Mixed-species colonization of solid surfaces in laboratory biofilms. Biofouling 3:23–34. doi:10.1080/08927019109378159.
    1. Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. 2010. Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol 8:471–480. doi:10.1038/nrmicro2381.
    1. Albenberg L, Esipova TV, Judge CP, Bittinger K, Chen J, Laughlin A, Grunberg S, Baldassano RN, Lewis JD, Li H, Thom SR, Bushman FD, Vinogradov SA, Wu GD. 2014. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology 147:1055–1063.e8. doi:10.1053/j.gastro.2014.07.020.
    1. Fuchs TM, Eisenreich W, Heesemann J, Goebel W. 2012. Metabolic adaptation of human pathogenic and related nonpathogenic bacteria to extra- and intracellular habitats. FEMS Microbiol Rev 36:435–462. doi:10.1111/j.1574-6976.2011.00301.x.
    1. Wessel AK, Arshad TA, Fitzpatrick M, Connell JL, Bonnecaze RT, Shear JB, Whiteley M. 2014. Oxygen limitation within a bacterial aggregate. mBio 5:e00992. doi:10.1128/mBio.00992-14.
    1. Yawata Y, Nguyen J, Stocker R, Rusconi R. 2016. Microfluidic studies of biofilm formation in dynamic environments. J Bacteriol 198:2589–2595. doi:10.1128/JB.00118-16.
    1. Blair JMA, Webber MA, Baylay AJ, Ogbolu DO, Piddock LJV. 2015. Molecular mechanisms of antibiotic resistance. Nat Rev Microbiol 13:42–51. doi:10.1038/nrmicro3380.
    1. Brunke S, Hube B. 2013. Two unlike cousins: Candida albicans and C. glabrata infection strategies. Cell Microbiol 15:701–708. doi:10.1111/cmi.12091.
    1. Taff HT, Mitchell KF, Edward JA, Andes DR. 2013. Mechanisms of Candida biofilm drug resistance. Future Microbiol 8:1325–1337. doi:10.2217/fmb.13.101.
    1. Lu Y, Su C, Unoje O, Liu H. 2014. Quorum sensing controls hyphal initiation in Candida albicans through Ubr1-mediated protein degradation. Proc Natl Acad Sci U S A 111:1975–1980. doi:10.1073/pnas.1318690111.
    1. Gray GW, Wilkinson SG. 1965. The action of ethylenediaminetetra-acetic acid on Pseudomonas aeruginosa. J Appl Microbiol 28:153–164. doi:10.1111/j.1365-2672.1965.tb04547.x.
    1. Vaara M. 1992. Agents that increase the permeability of the outer membrane. Microbiol Rev 56:395–411.
    1. Chang Y, Gu W, McLandsborough L. 2012. Low concentration of ethylenediaminetetraacetic acid (EDTA) affects biofilm formation of Listeria monocytogenes by inhibiting its initial adherence. Food Microbiol 29:10–17. doi:10.1016/j.fm.2011.07.009.
    1. Geesey GG, Wigglesworth-Cooksey B, Cooksey KE. 2000. Influence of calcium and other cations on surface adhesion of bacteria and diatoms: a review. Biofouling 15:195–205. doi:10.1080/08927010009386310.
    1. Leive L. 1965. A nonspecific increase in permeability in Escherichia coli produced by EDTA. Proc Natl Acad Sci U S A 53:745–750. doi:10.1073/pnas.53.4.745.
    1. Spires SS, Rebeiro PF, Miller M, Koss K, Wright PW, Talbot TR. 2018. Medically attended catheter complications are common in patients with outpatient central venous catheters. Infect Control Hosp Epidemiol 39:439–444. doi:10.1017/ice.2018.8.
    1. Merritt JH, Kadouri DE, O'Toole GA. 2005. Growing and analyzing static biofilms. Curr Protoc Microbiol Chapter 1:Unit 1B.1. doi:10.1002/9780471729259.mc01b01s00.
    1. Serrano-Fujarte I, López-Romero E, Reyna-López GE, Martínez-Gámez MA, Vega-González A, Cuéllar-Cruz M. 2015. Influence of culture media on biofilm formation by Candida species and response of sessile cells to antifungals and oxidative stress. BioMed Res Int 2015:1–15. doi:10.1155/2015/783639.
    1. CLSI. 2017. Performance standards for antimicrobial susceptibility testing; 23rd informational supplement. CLSI document M100-S27. CLSI, Wayne, PA.

Source: PubMed

3
Subskrybuj